Haverkate F - Search Results

1

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Thompson SG, et al. Among authors: haverkate f. N Engl J Med. 1995 Mar 9;332(10):635-41. doi: 10.1056/NEJM199503093321003. N Engl J Med. 1995. PMID: 7845427 Free article. Clinical Trial.

2

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Haverkate F, et al. Lancet. 1997 Feb 15;349(9050):462-6. doi: 10.1016/s0140-6736(96)07591-5. Lancet. 1997. PMID: 9040576 Clinical Trial.

3

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Juhan-Vague I, et al. Among authors: haverkate f. Circulation. 1996 Nov 1;94(9):2057-63. doi: 10.1161/01.cir.94.9.2057. Circulation. 1996. PMID: 8901651 Clinical Trial.

4

Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: haverkate f. Circulation. 1997 Jun 17;95(12):2623-7. doi: 10.1161/01.cir.95.12.2623. Circulation. 1997. PMID: 9193430

5

Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group.

Haverkate F, Thompson SG, Duckert F. Haverkate F, et al. Thromb Haemost. 1995 Apr;73(4):561-7. Thromb Haemost. 1995. PMID: 7495059

6

The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.

Haverkate F, Thompson SG, van de Loo JC. Haverkate F, et al. Ann Epidemiol. 1992 Jul;2(4):521-4. doi: 10.1016/1047-2797(92)90101-u. Ann Epidemiol. 1992. PMID: 1342302

7

The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT).

Thompson SG, Duckert F, Haverkate F, Thomson JM. Thompson SG, et al. Among authors: haverkate f. Thromb Haemost. 1989 Apr 25;61(2):301-6. Thromb Haemost. 1989. PMID: 2665175 Clinical Trial.

8

The impact of sequential quality assessment exercises on laboratory performance: the multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT).

Thompson SG, Calori G, Thomson JM, Haverkate F, Duckert F. Thompson SG, et al. Among authors: haverkate f. Thromb Haemost. 1991 Feb 12;65(2):149-52. Thromb Haemost. 1991. PMID: 2053100

9

Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.

Bots ML, Breteler MM, van Kooten F, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C. Bots ML, et al. Among authors: haverkate f. Haemostasis. 1998 May-Aug;28(3-4):216-22. doi: 10.1159/000022433. Haemostasis. 1998. PMID: 10420069

10

Thrombin, a link between coagulation activation and fibrinolysis.

Bertina RM, van Tilburg NH, de Fouw NJ, Haverkate F. Bertina RM, et al. Among authors: haverkate f. Ann N Y Acad Sci. 1992 Dec 4;667:239-48. doi: 10.1111/j.1749-6632.1992.tb51621.x. Ann N Y Acad Sci. 1992. PMID: 1309042 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results